| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |